TPST stock results show that Tempest Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. More
Articles
VTYX Stock Earnings: Ventyx Biosciences Beats EPS for Q2 2024
VTYX stock results show that Ventyx Biosciences beat analyst estimates for earnings per share the second quarter of 2024. More
VOR Stock Earnings: Vor Biopharma Beats EPS for Q2 2024
VOR stock results show that Vor Biopharma beat analyst estimates for earnings per share the second quarter of 2024. More
WATT Stock Earnings: Energous Beats EPS, Misses Revenue for Q2 2024
WATT stock results show that Energous beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. More
VSTM Stock Earnings: Verastem Beats EPS, Beats Revenue for Q2 2024
VSTM stock results show that Verastem beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
VTVT Stock Earnings: vTv Therapeutics Reported Results for Q2 2024
vTv Therapeutics just reported results for the second quarter of 2024. More
VINC Stock Earnings: Vincerx Pharma Beats EPS for Q2 2024
VINC stock results show that Vincerx Pharma beat analyst estimates for earnings per share the second quarter of 2024. More
